Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
14,737,485
-
Share change
-
+3,399,558
-
Total reported value
-
$65,873,000
-
Put/Call ratio
-
138%
-
Price per share
-
$4.47
-
Number of holders
-
43
-
Value change
-
+$22,950,830
-
Number of buys
-
32
-
Number of sells
-
16
Institutional Holders of ANTHERA PHARMACEUTICALS INC - COM NEW (ANTH) as of Q1 2015
As of 31 Mar 2015,
ANTHERA PHARMACEUTICALS INC - COM NEW (ANTH) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,737,485 shares.
The largest 10 holders included
Broadfin Capital, LLC, FRANKLIN RESOURCES INC, ProQuest Associates IV LLC, PERCEPTIVE ADVISORS LLC, Gruss Capital Management LP, VANGUARD GROUP INC, BOGLE INVESTMENT MANAGEMENT L P /DE/, Rhenman & Partners Asset Management AB, BlackRock Institutional Trust Company, N.A., and Abingworth LLP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.